Immunization with avirulent Salmonella typhimurium strain SL3235, a smooth, aroA derivative, was shown to induce high levels of resistance to challenge with virulent S. typhimurium in innately hypersusceptible C3H/HeJ mice and inherently resistant C3H/HeNCrlBR mice. Strain SL3235 is one of a class of avirulent aroA-derivatives made from various strains and species of SalmoneUla that are being considered as vaccine candidates for cattle and humans. This paper supports their efficacy and potential utility in this regard. In C3H/HeJ mice, immunity against over 1,000 50% lethal doses of virulent S. typhimurium was evident as early as 3 days after immunization and persisted for at least 7 months. Further, the vaccine was effective over a broad spectrum of doses, ranging from 104 to 106 organisms. Infection with SL3235 led to marked splenomegaly in both mouse strains. The relationship of splenomegaly to the growth kinetics and colonization by SL3235 in the spleens of infected C3H/HeJ and C3H/HeNCrlBR mice was followed. SL3235 initially multiplied slowly in the spleens of both mouse strains and then was rapidly cleared. Less multiplication was seen in the resistant C3H/HeNCrlBR mice than in C3H/HeJ mice. Maximum splenomegaly occurred after clearance of the organism had begun. Protection against virulent S. typhimunium persisted after virtually all of the SL3235 vaccine strain had been cleared from the spleen. Cross-protection against Listeria monocytogenes was evident, but had a later onset, waned by 21 days, and was not detectable by 1 month after vaccination. Demonstration of this cross-protection is consistent with the interpretation that SL3235 induces cellular immunity. One-week immune spleen cells adoptively transferred anti-S. typhimurium and anti-L. monocytogenes immunity. T cell-enriched fractions were ineffective in adoptive transfer, as were spleen cells taken 2 weeks or later after immunization. Protective capacity was in the adherent cell fraction and seemed to be associated with macrophages. Evidence for induction of a population of sensitized T cells was obtained by using a peritoneal exudate T-lymphocyte proliferation assay on peritoneal T lymphocytes collected 1 to 3 months after SL3235 infection.
C3H/HeJ mice and inherently resistant C3H/HeNCrlBR mice. Strain SL3235 is one of a class of avirulent aroA-derivatives made from various strains and species of SalmoneUla that are being considered as vaccine candidates for cattle and humans. This paper supports their efficacy and potential utility in this regard. In C3H/HeJ mice, immunity against over 1,000 50% lethal doses of virulent S. typhimurium was evident as early as 3 days after immunization and persisted for at least 7 months. Further, the vaccine was effective over a broad spectrum of doses, ranging from 104 to 106 organisms. Infection with SL3235 led to marked splenomegaly in both mouse strains. The relationship of splenomegaly to the growth kinetics and colonization by SL3235 in the spleens of infected C3H/HeJ and C3H/HeNCrlBR mice was followed. SL3235 initially multiplied slowly in the spleens of both mouse strains and then was rapidly cleared. Less multiplication was seen in the resistant C3H/HeNCrlBR mice than in C3H/HeJ mice. Maximum splenomegaly occurred after clearance of the organism had begun. Protection against virulent S. typhimunium persisted after virtually all of the SL3235 vaccine strain had been cleared from the spleen. Cross-protection against Listeria monocytogenes was evident, but had a later onset, waned by 21 days, and was not detectable by 1 month after vaccination. Demonstration of this cross-protection is consistent with the interpretation that SL3235 induces cellular immunity. One-week immune spleen cells adoptively transferred anti-S. typhimurium and anti-L. monocytogenes immunity. T cell-enriched fractions were ineffective in adoptive transfer, as were spleen cells taken 2 weeks or later after immunization. Protective capacity was in the adherent cell fraction and seemed to be associated with macrophages. Evidence for induction of a population of sensitized T cells was obtained by using a peritoneal exudate T-lymphocyte proliferation assay on peritoneal T lymphocytes collected 1 to 3 months after SL3235 infection.
C3H/HeJ mice are innately hypersusceptible to Salmonella typhimurium infection, with a 50% lethal dose (LD50) of <7 cells (8) . In addition, these mice are difficult to immunize with a variety of nonviable vaccines that give good protection in other mouse strains, such as the C3H/HeNCrlBR mice, with greater innate resistance to S. typhimurium (7, 10) . Hoiseth and Stocker have shown that immunization with a live, avirulent S. typhimurium derivative, strain SL3235, which is deficient in aromatic biosynthesis, confers high levels of protection on hypersusceptible BALB/c mice (14) . Like the C3H/HeJ animals, this strain is also difficult to immunize with nonviable vaccines, but their S. typhimurium susceptibility is coded for by a different genetic locus (27) . S. typhimurium derivatives with similar defects in aromatic biosynthesis are being considered as potential vaccine strains for cattle (28, 34) and humans (14) .
We have found that strain SL3235 induces high levels of immunity in C3H/HeJ mice (9) , but without engendering delayed hypersensitivity as measured by footpad testing (17) . The present study was undertaken to investigate the mechanisms of protection by this organism in C3H/HeJ mice. Inherently S. typhimurium-resistant C3H/HeNCrlBR mice were used as controls. Our results show that immunization with SL3235 leads to long-lasting, high levels of 606 KILLAR AND EISENSTEIN ing to aro+. One of these nonreverting variants was avirulent for BALB/c mice and was designated SL3235 (14) .
S. typhimurium strain W118-2, which is mouse virulent (LD50 <7 cells in C3H/HeJ mice and 103 cells in C3H/ HeNCrIBR mice), was originally obtained from Samuel Formal, Walter Reed Army Institute of Medical Research, Washington, D.C., and has been used extensively in our laboratory (1) . The LD50 was assumed to be one cell. L. monocytogenes strain EDG was obtained from Michael Largen, Temple University School of Medicine, and originated from Trudeau Institute stock.
Bacterial culture. For immunization or challenge, lyophilized SL3235 or W118-2 cells were rehydrated with brain heart infusion broth and streaked on blood agar. Brain heart infusion broth (10 ml) was inoculated with five colonies from the blood agar plate and incubated for 4 h at 37°C. A 5-ml sample of this log-phase culture was then transferred to 50 ml of brain heart infusion broth and incubated for an additional 2 h at 37°C with shaking. This protocol yielded organisms that were in the log phase, 99% viable, and at a concentration of approximately 108 cells per ml. The culture was placed on ice, the number of organisms was estimated by counting in a Petroff-Hauser chamber, and dilutions were made in saline to achieve the desired concentration of organisms. The exact number of S. typhimurium organisms injected was determined by duplicate plate counts.
L. monocytogenes colonies were picked from blood agar plates and grown in tryptone broth to log phase. Bacterial numbers were estimated by optical density. The suspension was diluted to the desired concentration in saline, and bacterial numbers were confirmed by plate counts.
Vaccination. For protection experiments, mice were immunized intraperitoneally (i.p.) with live cells of S. typhimurium strain SL3235, 1 x 104 to 1.25 x 10' CFU, suspended in 0.5 ml of saline. At various times thereafter, these mice and controls were challenged i.p. with S. typhimurium strain W118-2 or L. monocytogenes, and deaths were scored for 60 days after challenge.
Colonization and splenomegaly. Groups of mice immunized with S. typhimurium strain SL3235 were sacrificed on days 1, 3, 5, 7, 10, 15, and 21 after vaccination (six per time point). Their spleens were removed, individually weighed, and then homogenized with a Tekmar SDT Tissuemizer (Tekmar Co., Cincinnati, Ohio) in a total volume of 5 ml sterile distilled water. A 0.1-ml sample of the homogenate or an appropriate dilution was plated on eosin-methylene blue agar, and the number of lac-colonies was counted.
Spleen cell transfers. Donor C3H/HeJ mice were immunized i.p. with live S. typhimurium strain SL3235 organisms. At different time after immunization, spleens were removed from the donor animals, and cell suspensions were prepared by pushing the spleens through a wire mesh. Erythrocytes were lysed by suspending the cells in Tris buffer with 0.75% ammonium chloride and incubating on ice for 5 Fractionation of spleen cells on nylon wool. Spleen cells that had been treated with ammonium chloride were suspended at a concentration of 2 x 107 viable cells per ml in RPMI-1640 with 10% fetal calf serum, and 10 ml was plated onto 100-mm tissue culture dishes. After 1 h of incubation at 37°C in 5% C02, the nonadherent cells were collected, and the procedure was repeated. The nonadherent cells from this second passage on tissue culture dishes were collected and suspended to 108 cells per ml in RPMI-1640 with 10% fetal calf serum. A 2-ml sample of the cell suspension was applied to a nylon wool column that had previously been prepared as described by Julius et al. (15) . Nonadherent cells were collected by washing the column with warm medium. Adherent cells were collected by washing the column with cold medium and squeezing the nylon wool. Enrichment of cell populations was assessed by measuring proliferative responses to B-and T-cell mitogens (8) .
Enrichment for splenic macrophages. Populations enriched for macrophages were prepared by the method of Freundlich and Avdalovic with gelatin-and plasma-coated tissue culture flasks, a method which purifies monocytes and macrophages by their fibronectin receptors (11 Comparison of bacterial growth and extent of splenomegaly shows that maximal splenomegaly (day 15) occurred after growth of the organism was under control in the spleen (maximum colonization occurred at day 10 in C3H/HeJ mice and day 7 in C3H/HeNCrlBR mice). Cell transfers. The fact that SL3235 induces high levels of immunity in C3H/HeJ mice that are not protected by nonviable vaccines, and the observed transient cross-protection to L. monocytogenes, are consistent with induction of cellular immunity (4). However, C3H/HeJ mice do not give positive footpad responses to a culture supernatant antigen (17) . Therefore the presence of immune T cells was sought by cell transfer. Spleen cells from SL3235-immunized C3H/HeJ mice are capable of transferring protection to nonimmune C3H/HeJ recipients (Table 5 ), but only when harvested at 1 week after immunization, even though immunized mice are resistant to S. typhimurium for at least 7 months (Table 3) . Experiments were then performed to determine the cell type(s) responsible for transfer of protection in 1-week immune spleens. When immune spleen cells were fractionated on nylon wool columns (Table 6 ), neither nylon woolnonadherent cells, which are enriched for T cells as assessed by mitogen responses, nor nylon wool-adherent cells (enriched for B cells) protected any of the recipients. Further, purification of cells by plastic adherence was found to decrease the protective capacity of the spleen cells.
To test the hypothesis that activated macrophages might be the protective cell in 1-week immune spleens, recipients (Table  7 ). This experiment suggests that activated macrophages are present in the immune spleen cell populations. Cell populations enriched for macrophages were then tested for their ability to transfer resistance. In both experiments, immune adherent cells were capable of protecting recipients, whereas nonadherent cells were ineffective (Table 8).
As cell transfer experiments failed to reveal the presence of immune T cells in SL3235-immunized C3H/HeJ mice, a PETLs proliferation assay was carried out. PETLs from mice that had been immunized with SL3235 proliferated more in response to the S. typhimurium antigens than did those from nonimmune mice ( Table 9 ). Since endotoxin-protein is a B-cell mitogen (36), the observation that it gives only low levels of stimulation of PETLs from control mice confirms that the cell populations used in the assay were mainly T lymphocytes. Further, the excellent stimulation obtained when endotoxin protein or acetone-killed S. typh- bMice were uninfected or had been infected with SL3235 1 to 3 months before peritoneal cell elicitation with proteose-peptone. Peritoneal cells were collected 3 days after elicitation.
C SI, Stimulation index.
imurium strain W118-2 cells were added to immune PETLs as compared with controls suggests that this assay is detecting specifically S. typhimurium-immune T cells in SL3235-immunized C3H/HeJ mice. DISCUSSION These studies show that the live, avirulent S. typhimurium mutant, strain SL3235, provides high levels of protection in both inherently S. typhimurium-hypersusceptible C3H/HeJ mice and innately resistant C3H/HeJ mice. Demonstration of protection by this vaccine in C3H/HeJ mice is particularly noteworthy, since it has been shown that these mice are poorly protected by many nonviable vaccines and not significantly protected against lethality by a different live, avirulent Salmonella mutant (7, 10, 26, 29) . Specific protection against challenge with virulent S. typhimurium cells persists for at least 7 months. These results confirm and extend those of Hoiseth and Stocker (14) , showing the potential utility of aro-derivatives for use as vaccines against systemic Salmonella infection. Also, we have observed that SL3235 protects against oral challenge (M. Phillips, T. K. Eisenstein, and B. M. Sultzer, Abstr. Annu. Meet. Am. Soc. Microbiol., abstr. no. E44, p. 83, 1983).
The observation that strain SL3235 multiplies to some extent in S. typhimurium-susceptible C3H/HeJ mice, yet does not kill them, confirms the nonvirulence of this arostrain. Its nonvirulence is attributed (14) to its requirement for two aromatic compounds, p-aminobenzoate and 2,3-dihydroxybenzoate, thought to be absent in host tissues or present at insufficient concentration for normal bacterial growth. The number of CFU of strain SL3235 in the spleens of C3H/HeJ mice increased slowly for some days after challenge, with a doubling time of 3.4 days, compared with a doubling time of 9.9 h for a virulent strain, W118-2 (8); the peak number of CFU per spleen, reached on day 10, was about 10 times the number of CFU inoculated i.p. The ability to undergo some in vivo replication has been shown to be an important attribute for vaccine strains of Salmonella (6) and Mycobacterium bovis BCG (3). This slow and limited growth of strain SL3235 in the C3H/HeJ mice perhaps reflects the utilization of relevant metabolites present within the bacteria at the time of inoculation. Note that in the present experiments the inoculum consisted of bacteria from a logarithmicphase culture grown in brain heart infusion broth, which perhaps resulted in a good intracellular store of these metabolites. Cessation of multiplication may have been due to exhaustion of stored metabolites, although the observation that clearing of SL3235 from the spleen began earlier in the inherently resistant C3H/HeNCrlBR mice than in the innately hypersusceptible C3H/HeJ mice suggests that growth is probably terminated by a host defense mechanism. By 21 days post-immunization, over 99.9% of the initial inoculum had been cleared from the spleens of both strains of mice.
The studies reported here on protection of C3H/HeJ mice by SL3235 suggest that this attenuated strain induces cellular immunity, involving both nonspecific and specific resistance. The appearance of resistance to L. monocytogenes and protection against S. typhimurium as early as 3 days after immunization implicates nonspecific activation of macrophages, as has been shown for Salmonella and other live, intracellular organisms (4, 20, 37) .
Cell transfer experiments support the hypothesis that early after immunization, nonspecific resistance mediated by activated macrophages is responsible for protection against S. typhimurium and L. monocytogenes. It appears from the cell fractionation studies that macrophages are responsible for the transfer of increased resistance by spleen cells from donor mice that had been immunized 1 week previously. It is highly unlikely that transfer of protection with 1-week immune spleen cells is simply due to carry over of live SL3235. Spleen cell recipients were challenged 24 h after cell transfer, and increased resistance did not develop 24 h after receiving SL3235 (Table 2) . Also, control groups of mice in each experiment that were injected with the approximate number of SL3235 present in the immune spleen cell suspensions were not protected.
We have obtained direct evidence that the macrophages of SL3235-immunized mice are activated, since their peritoneal cells acquire tumoricidal activity (unpublished observations). Hepatosplenomegaly alone is not a sufficient condition for increased S. typhimurium resistance, since glucan gives marked hepatosplenomegaly, but does not protect against S. typhimurium infection (Tamada and Eisenstein, manuscript in preparation); as shown in this paper, mice are still immune to 85 LD50s of L. monocytogenes at 21 days after SL3235 immunization (Table 4) , but splenomegaly has almost disappeared.
The mechanism of the long-term, specific resistance to S. typhimurium infection induced by SL3235 has not been completely elucidated. It 30 days may not be a valid endpoint.) Our cell fractionation studies consistently showed lack of transfer by nylon wool-nonadherent cells, which were confirmed to be T enriched by their concanavalin A and phytohemagglutinin responsiveness. B cell-enriched, nylon wool-adherent cells (squeezed out) were also inactive. It is puzzling that SL3235 induces long-lasting immunity to S. typhimurium in C3H/HeJ mice without demonstrable delayed-type hypersensitivity to a proven S. typhimurium elicitin (17) and without a recoverable T-cell population that can transfer immunity. Protective activity was found only in the fraction of cells which binds to fibronectin and which was enriched for cells that ingested latex beads and were considered macrophages. The macrophage transfer studies are somewhat difficult to interpret, since equivalent numbers of fibronectin-adherent cells were needed to transfer protection as whole spleen cells. One would have expected that fewer macrophages would have been needed, and the reasons for a failure to achieve an increase in specific activity are not clear. Further, the possibility must be considered that the reason why neither nylon wool-nonadherent nor -adherent cells were protective is because the activated T cells stuck to the column more avidly and were not dislodged by squeezing. Other explanations can also be sought for the failure to retrieve active T cell fractions. We have shown that SL3235 induces potent suppression of spleen cells of immunized mice to a panel of B-and T-cell mitogens (9) . This suppression is mediated by splenic macrophages (J.-C. Lee (12, 19) . Still another possible explanation for failure to transfer protection with T cell-enriched cell populations may be the result of using the C3H/HeJ mouse as a recipient. These animals have a defect in macrophage activation (30, 31) , and transfer of immune T cells may be insufficient to confer immunity. Similar T-cell fractions transferred to a nondefective histocompatible mouse strain might be successful. Finally, cell transfer at later times ( The presence of specifically immune T cells in SL3235-immunized mice, however, was demonstrated in the PETLs assay. This T-cell population may be more effective in transferring protection than splenic T cells, and these experiments are currently being pursued.
In conclusion, the experiments presented in this paper show that immunization with live S. typhimurium strain SL3235 gives high levels of long-lasting protection in the difficult-to-immunize, hypersusceptible C3H/HeJ mice and confirm the potential utility of this class of derivatives as Salmonella vaccines. The results of the specific and nonspecific protection studies suggest that SL3235 induces cellular immunity. The activation of macrophages was found to be responsible for the transient, nonspecific resistance expressed in SL3235-immunized mice. The mechanism of long-lasting specific resistance to Salmonella spp. has not been defined using the classic assays of delayed-type hypersensitivity and cell transfer; however, the presence of immune T cells has been demonstrated in a PETLs proliferation assay.
